|
SGOL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90810001132746E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.420900E-03 |
| Normal-vs-Stage2 |
1.494030E-01 |
| Normal-vs-Stage3 |
4.1740999999984E-05 |
| Normal-vs-Stage4 |
2.232100E-02 |
| Stage1-vs-Stage2 |
5.227000E-01 |
| Stage1-vs-Stage3 |
2.013900E-04 |
| Stage1-vs-Stage4 |
9.482000E-03 |
| Stage2-vs-Stage3 |
6.483600E-02 |
| Stage2-vs-Stage4 |
1.532850E-01 |
| Stage3-vs-Stage4 |
9.114400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26590000043758E-07 |
| Normal-vs-AfricanAmerican |
6.884600E-03 |
| Normal-vs-Asian |
1.704410E-01 |
| Caucasian-vs-AfricanAmerican |
3.296200E-01 |
| Caucasian-vs-Asian |
6.955800E-01 |
| AfricanAmerican-vs-Asian |
3.761000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31339999998037E-06 |
| Normal-vs-Female |
1.016260E-04 |
| Male-vs-Female |
1.848090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.515010E-03 |
| Normal-vs-Extreme_Weight |
2.415600E-03 |
| Normal-vs-Obese |
1.231700E-04 |
| Normal-vs-Extreme_Obese |
6.059800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.582000E-02 |
| Normal_Weight-vs-Obese |
7.481800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.216400E-03 |
| Extreme_Weight-vs-Obese |
1.065900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.004500E-02 |
| Obese-vs-Extreme_Obese |
7.988100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.498430E-02 |
| Normal-vs-Age(41-60Yrs) |
6.13389999903902E-08 |
| Normal-vs-Age(61-80Yrs) |
1.883150E-03 |
| Normal-vs-Age(81-100Yrs) |
1.674990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.473700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.313500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.786000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.655000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.124960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.503180E-03 |
| Normal-VS-Type2 PRCC |
3.61899999999915E-05 |
| Normal-VS-KIRP CIMP |
1.797390E-03 |
| Normal-VS-Unclassified PRCC |
5.238600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.349600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.084300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.801010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.323100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.155800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.657400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.916800E-03 |
| Normal-vs-N1 |
1.175200E-04 |
| Normal-vs-N2 |
1.709630E-01 |
| N0-vs-N1 |
1.876780E-03 |
| N0-vs-N2 |
1.228210E-01 |
| N1-vs-N2 |
5.106600E-01 |
|
|
